Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(97)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(122)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
-
GC11892
AEE788 (NVP-AEE788)
6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺,NVP-AEE 788
An inhibitor of EGFR and VEGFR tyrosine kinases
-
GC13394
Ispinesib (SB-715992)
伊斯平斯; SB-715992
An Eg5 inhibitor
-
GC14144
Fludarabine
氟达拉滨; F-ara-A; NSC 118218
Fludarabine是一种抑制DNA合成的嘌呤类似物。
-
GC16868
Sulfasalazine
柳氮磺吡啶; NSC 667219
Sulfasalazine是一种磺胺类药物。
-
GC16732
TSU-68 (SU6668,Orantinib)
SU6668; TSU-68
An inhibitor of select receptor tyrosine kinases
-
GC15166
Perindopril Erbumine
培哚普利叔丁胺; Perindopril tert-butylamine salt; S-9490 erbumine
An orally active ACE inhibitor
-
GC17955
Vatalanib (PTK787) 2HCl
瓦他拉尼,PTK787 dihydrochloride; CGP-797870 dihydrochloride; ZK-222584 dihydrochloride
A potent and selective VEGF receptor inhibitor
-
GC11202
Epothilone A
埃博霉素A,Epo A
An antimicrotubule agent
-
GC17094
Acitretin
阿维A; Ro 10-1670
A retinoid
-
GC13598
MGCD-265
N-(3-氟-4-(2-(1-甲基-1H-咪唑-4-基)噻吩并[3,2-B]吡啶-7-氧基)苯基氨基硫代甲酰基)-2-苯乙酰胺
A c-Met and VEGFR2 inhibitor
-
GC16818
BX-912
A potent inhibitor of PDK1
-
GC14957
OSI-930
噻尔非尼
A dual inhibitor of Kit and VEGFR2
-
GC17240
Epothilone B (EPO906, Patupilone)
埃博霉素B; EPO 906; Patupilone
Microtubule stabilizing agent
-
GC10662
WYE-354
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯
Potent inhibitor of mTOR in both mTORC1 and mTORC2
-
GC13091
CP-724714
2-甲氧基-N-[(2E)-3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺
A selective HER2/ErbB2 tyrosine kinase inhibitor
-
GC15779
Cabozantinib (XL184, BMS-907351)
卡博替尼; XL184; BMS-907351
Cabozantinib (XL184,BMS-907351) 是一种新型 MET 和 VEGFR2 抑制剂,可同时抑制转移、血管生成和肿瘤生长。
-
GC10591
Nelarabine
奈拉滨; 506U78; GW 506U78; Nelzarabine
A nucleoside analog used in the treatment of leukemia
-
GC13044
17-DMAG (Alvespimycin) HCl
阿螺旋霉素盐酸盐; 17-DMAG hydrochloride; KOS-1022; BMS 826476
17-DMAG (Alvespimycin) HCl是一种有效的Hsp90的抑制剂,其IC50值为62nM。
-
GC15665
Quercetin dihydrate
二水槲皮素
槲皮素二水合物是一种天然类黄酮,是重组 SIRT1 的刺激剂和 PI3K 抑制剂,对 PI3K γ、PI3K δ 和 PI3K β 的 IC50 分别为 2.4 μM、3.0 μM 和 5.4 μM。
-
GC13968
SB202190 (FHPI)
4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑
SB 202190是一种选择性p38 MAP激酶抑制剂,对p38α和p38β2的IC50分别为50 nM和100 nM。
-
GC17958
Linifanib (ABT-869)
利尼伐尼,ABT-869; AL-39324
A dual VEGFR and PDGFR family kinase inhibitor
-
GC12709
XL147
XL147 analogue
An analog of XL147
-
GC11396
SNS-032 (BMS-387032)
BMS-387032
A Cdk2, Cdk7, and Cdk9 inhibitor
-
GC10686
Epirubicin HCl
盐酸表柔比星; 4'-Epidoxorubicin hydrochloride
Epirubicin HCl是一种具有口服活性的DNA topoisomerase II特异性抑制剂,IC50为12μM。
-
GC10893
Dutasteride
度他雄胺; GG 745; GI 198745
An inhibitor of steroid 5α-reductase
-
GC11499
Enzastaurin (LY317615)
恩扎妥林; LY317615
Enzastaurin (LY317615)是一种ATP竞争性、选择性的PKCβ抑制剂,IC50值为6nM。
-
GC13697
AG-1024
Tyrphostin AG 1024
AG-1024是一种可逆的,竞争性和选择性的胰岛素样生长因子-1受体(IGF-1R)抑制剂,IC50值为7µM。AG-1024能够抑制胰岛素受体(IR)的磷酸化,IC50值为57µM。
-
GC14485
Dacarbazine
达卡巴嗪; Imidazole Carboxamide
A DNA alkylating prodrug
-
GC10509
Cladribine
克拉屈滨; 2-Chloro-2′-deoxyadenosine; CldAdo; 2CdA
A nucleoside analog and prodrug form of 2-CdATP
-
GC13410
Masitinib (AB1010)
马赛替尼; AB1010
An inhibitor of c-Kit
-
GC15617
Etoposide
依托泊苷; VP-16; VP-16-213
Etoposide(VP-16)是一种非特异性拓扑异构酶II(Topoisomerase II)抑制剂,IC50值为59.2 μM。
-
GC13636
BIBR 1532
2-[[(2E)-3-(2-萘基)-1-氧代-2-丁烯基]氨基]苯甲酸
BIBR 1532是一种强效的小分子人类端粒酶抑制剂,对端粒酶的抑制作用的IC50值为5μM。BIBR 1532会导致端粒缩短并减少肿瘤细胞的增殖。
-
GC12989
PD184352 (CI-1040)
2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺,PD 184352
A potent MEK inhibitor
-
GC11089
SU11274
N-(3-氯苯基)-N-甲基-3-[[3,5-二甲基-4-[(4-甲基哌嗪-1-基)羰基-1H-吡咯-2-基]亚甲基]-2-氧代-2,3-二氢-1H-吲哚-5-磺酰胺,PKI-SU11274
A potent, selective inhibitor of c-Met
-
GC10610
Adapalene
阿达帕林; CD271
An RARβ and RARγ agonist
-
GC11733
PHA-665752
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氢-2-氧代-3H-吲哚-3-亚基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷
A selective c-Met inhibitor
-
GC14102
Genistein
染料木素; NPI 031L
染料木黄酮是一种异黄酮,属于类黄酮化合物,存在于多种植物中。
-
GC11165
PI-103
PI-103是一种有效的细胞渗透性多靶点抑制剂,主要作用于PI3K和mTOR信号通路。
-
GC15219
Clofarabine
氯法拉滨
A ribonucleotide reductase and DNA polymerase-α inhibitor
-
GC10744
Bendamustine HCl
盐酸苯达莫司汀; SDX-105
A DNA alkylating agent
-
GC11511
Vincristine sulfate
硫酸长春新碱; Leurocristine sulfate; NSC-67574 sulfate; 22-Oxovincaleukoblastine sulfate
An antimitotic inhibitor of tubulin polymerization
-
GC12838
Edaravone
依达拉奉; MCI-186
Edaravone是一种经典的自由基清除剂,作为有机小分子可穿越血脑屏障,为脑细胞提供保护。
-
GC15344
SP 600125
吡唑蒽酮
SP 600125是一种具有口服活性的、可逆的、具有选择性的ATP竞争性JNK 抑制剂,对JNK1、JNK2和JNK3的IC50分别为40、40和90nM。SP 600125常用于卵巢癌、肿瘤、帕金森病 (PD)、乳腺癌和哮喘的研究。
-
GC17621
TPCA-1
5-(4-氟苯基)-2-脲基噻吩-3-甲酰胺
A selective inhibitor of IKK2
-
GC17943
PD173074
PD 173074,PD-173074
PD173074是一种ATP竞争性FGFR1和VEGFR2抑制剂,IC50值分别为26nM和100-200nM,对FGFR1的选择性高于PDGFR和c-Src。
-
GC16694
TAE684 (NVP-TAE684)
TAE 684
A selective ALK inhibitor
-
GC15485
LY 294002
LY294002/PI3K抑制剂
LY294002是第一个合成的PI3Kα、δ和β抑制剂。
-
GC16499
Sorafenib Tosylate
甲苯磺酸索拉非尼; Bay 43-9006 Tosylate
A multi-kinase inhibitor
-
GC17198
Cycloheximide
Naramycin A; Actidione; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide
环己酰亚胺是一种抗生素,它在翻译水平上抑制蛋白质合成,仅对真核细胞的细胞质(80s)核糖体起作用。
-
GC17030
AZD6244(Selumetinib)
司美替尼; AZD6244; ARRY-142886
AZD6244(Selumetinib)是一种口服小分子特异性MEK1/2蛋白ATP非竞争性抑制剂,IC50值为14.1± 0.79nM。